David First - Jan 24, 2023 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role
Chief People Officer
Signature
/s/Lawrence Knopf as attorney in fact for David First
Stock symbol
SQZB
Transactions as of
Jan 24, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2023, 03:44 PM
Previous filing
Feb 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +200K $0.00 200K Jan 24, 2023 Common Stock 200K $0.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.